Publicacións nas que colabora con MARIANA LANDIN PEREZ (23)

2013

  1. Effect of storage conditions on the stability of β-lapachone in solid state and in solution

    Journal of Pharmacy and Pharmacology, Vol. 65, Núm. 6, pp. 798-806

2012

  1. Fast dissolving β-lapachone particles and tablets: An approach using surface adsorption technique

    Drug Development and Industrial Pharmacy, Vol. 38, Núm. 7, pp. 866-871

  2. Temperature-sensitive gels for intratumoral delivery of β-lapachone: Effect of cyclodextrins and ethanol

    The Scientific World Journal, Vol. 2012

2011

  1. Light effect on the stability of β-lapachone in solution: Pathways and kinetics of degradation

    Journal of Pharmacy and Pharmacology, Vol. 63, Núm. 9, pp. 1156-1160

2009

  1. Validação da metodologia analítica e desenvolvimento do teste de dissolução para o antineoplásico beta-lapachona

    Latin American Journal of Pharmacy, Vol. 28, Núm. 6, pp. 805-811

2008

  1. Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 3, pp. 871-877

  2. Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs

    International Journal of Pharmaceutics, Vol. 349, Núm. 1-2, pp. 11-18

  3. Konjac glucomannan/xanthan gum enzyme sensitive binary mixtures for colonic drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 2, pp. 573-581

2007

  1. Compatibility of the antitumoral β-lapachone with different solid dosage forms excipients

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 45, Núm. 4, pp. 590-598

2006

  1. Characterization of diffusion of macromolecules in konjac glucomannan solutions and gels by fluorescence recovery after photobleaching technique

    International Journal of Pharmaceutics, Vol. 316, Núm. 1-2, pp. 37-46

  2. β-Lapachone

    Acta Crystallographica Section C: Crystal Structure Communications, Vol. 62, Núm. 8

2005

  1. A comparison of trehalose dihydrate and mannitol as stabilizing agents for dicalcium phosphate dihydrate based tablets

    Drug Development and Industrial Pharmacy, Vol. 31, Núm. 3, pp. 249-256

1995

  1. Chemical stability of acetylsalicylic acid in tablets prepared with different particle size fractions of a commercial brand of dicalcium phosphate dihydrate

    International Journal of Pharmaceutics, Vol. 123, Núm. 1, pp. 143-144

1994

  1. Chemical stability of acetylsalicylic acid in tablets prepared with different commercial brands of dicalcium phosphate dihydrate

    International Journal of Pharmaceutics, Vol. 107, Núm. 3, pp. 247-249

  2. Dicalcium phosphate dihydrate for direct compression: Characterization and intermanufacturer variability

    International Journal of Pharmaceutics, Vol. 109, Núm. 1, pp. 1-8

  3. The effect of country of origin on the properties of dicalcium phosphate dihydrate powder

    International Journal of Pharmaceutics, Vol. 103, Núm. 1, pp. 9-18

1993

  1. Comparison of two varieties of microcrystalline cellulose as filler-binders II. Hydrochlorothiazide tablets

    Drug Development and Industrial Pharmacy, Vol. 19, Núm. 10, pp. 1211-1220

  2. Effect of batch variation and source of pulp on the properties of microcrystalline cellulose

    International Journal of Pharmaceutics, Vol. 91, Núm. 2-3, pp. 133-141

  3. Effect of country of origin on the properties of microcrystalline cellulose

    International Journal of Pharmaceutics, Vol. 91, Núm. 2-3, pp. 123-131

  4. Influence of microcrystalline cellulose source and batch variation on the tabletting behaviour and stability of prednisone formulations

    International Journal of Pharmaceutics, Vol. 91, Núm. 2-3, pp. 143-149